The Future of Metastatic and Unresectable Melanoma Treatment
Source: OncLive, January 2024
The panel concludes their discussion with a call for continued research and collaboration, emphasizing the need for more understanding of targeted therapies, monitoring tools like ctDNA, and ongoing development in the field of BRAF mutant melanoma treatment.
